Long-Term Cost Effectiveness of Interferon-beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis : An Econometric Model.
Lepen C, Coyle P, Vollmer T, Blumhardt L, Lilliu H, Beresniak A. Long-Term Cost Effectiveness of Interferon-beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis : An Econometric Model. Clin Drug Investig. 2003; 23(9):571-81.